Trends in pharmacological management of paediatric patients with type 2 diabetes from 2000 to 2023 in German‐speaking countries: Analysis based on the Diabetes Prospective Follow‐up Registry

Documenti analoghi

• An overview of obesity‐related complications: The epidemiological evidence linking body weight and other markers of obesity to adverse health outcomes
  di: Matthias Blüher
  Pubblicazione: (2025)
• Highly Uncontrolled Cardiovascular Risk in Emerging Adults With Paediatric‐Onset Type 1 Diabetes—A Cross‐Sectional Analysis From the Diabetes Prospective Follow‐Up Registry DPV
  di: Alena Welters, et al.
  Pubblicazione: (2026)
• Diagnosis, treatment, management and monitoring of patients with tyrosinaemia type 1: Consensus group recommendations from the German‐speaking countries
  di: Anibh M. Das, et al.
  Pubblicazione: (2024)
• Analysis of patient characteristics and safety of insulin glargine U300 use in 21 359 patients with type‐2 diabetes and chronic kidney disease: DPV registry study
  di: Anjaly Vijayan, et al.
  Pubblicazione: (2025)
• Efficacy, Safety and Pharmacokinetics of Semaglutide 1.7 mg for Obesity Treatment in Adolescents: A Model‐Informed Drug Development Approach
  di: Anders Strathe, et al.
  Pubblicazione: (2026)